REBECCA BROWN: Open Payments
NPI 1750695375 · ADDISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 16 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $464 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $111 |
| Astellas Pharma US Inc | 3 | $53 |
| Bolton Medical Inc | 2 | $52 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $25 |
| Lilly USA, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Abbott Laboratories | 1 | $14 |
Products named: Veozah, THORAFLEX HYBRID, Wegovy, Ozempic, MOUNJARO, Dexcom G6 Transmitter, General - Ultrasound, ESPRIT.
Industry payments across TX — which companies pay providers there.
